Crescita Therapeutics (TSX:CTX) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSX:CTX Crescita Therapeutics Inc TSX:CTX
20 GF Score
Price C$0.79
! 5 Warning Signs
View Full Analysis

What is Crescita Therapeutics Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

TSX:CTX
20GF Score
Crescita Therapeutics Inc TSX:CTX
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Crescita Therapeutics Business Description

Address 2805, Place Louis-R-Renaud, Laval, QC, CAN, H7V 0A3
Crescita Therapeutics Inc. is a Canadian commercial dermatology company that develops, manufactures, and sells skincare and prescription dermatology products. It operates through three segments: Commercial Skincare, which markets non-prescription skincare brands in Canada and internationally; Licensing and Royalties, which derives revenue from out-licensing its proprietary drug delivery platforms and patented formulations; and Manufacturing and Services, which provides contract manufacturing and development services to third parties. The company's delivery technologies are designed to facilitate the penetration of active ingredients into or through the skin. Its customer base includes consumers, healthcare professionals, and pharmaceutical or cosmetic partners. Revenue is generated primarily from commercial skincare product sales in Canada, followed by the United States and other international markets, supplemented by licensing, royalty, and manufacturing service income.
20GF Score

Get the complete analysis for TSX:CTX

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.79
Price